Evidence map›Paper›PMID 30864147›Full record

ReviewClinical and experimental immunology2019

Mechanisms of human FoxP3

M Attias, T Al-Aubodah, C A Piccirillo

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical and experimental immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 100 citations in OpenAlex.

  1. Review
  2. Review
  3. From Tregs to tissue remodelling: FOXP3 and IL-35 in the inflammatory landscape of nasal polyps.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Regulatory T cells in hypoxic environments.Frontiers in immunology · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Anti-PD-1 amplifies costimulation in melanoma-infiltrating TJournal for immunotherapy of cancer · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Impacts of rs7528684 (-169T/C) onFrontiers in genetics · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M AttiasProgram in Infectious Diseases and Immunology in Global Health, The Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.ORCID 0000-0002-8090-0425
T Al-AubodahProgram in Infectious Diseases and Immunology in Global Health, The Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.ORCID 0000-0002-4348-3159
C A PiccirilloProgram in Infectious Diseases and Immunology in Global Health, The Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.ORCID 0000-0002-7703-6779
McGill University Health Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulatory T (T

Indexed as

Arthritis, RheumatoidCell DifferentiationCell LineageDiabetes Mellitus, Type 1DiarrheaEpigenesis, GeneticForkhead Transcription FactorsGenetic Diseases, X-LinkedHumansImmune System DiseasesImmunotherapyInflammationModels, ImmunologicalNeoplasmsPeripheral ToleranceReceptors, Antigen, T-CellForkhead Transcription FactorsFOXP3 protein, humanReceptors, Antigen, T-Cellantigen specificitycell therapyhuman immunologyregulatory T cell dysfunctionregulatory T cells

Identifiers

PMID30864147
PMCPMC6591147
OpenAlexW2922269696

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.